CSF2 and myeloid sarcoma: In addition, blocking IL-2 + IL-12 significantly reduced the percentage of NK cells expressing GM-CSF in MS (Wilcoxon test: MS n = 10, p = 0.01; HC n = 7, p = 0.53; Figure 7E,F).